Literature DB >> 1590766

Increases in intestinal glucose absorption and hepatic glucose uptake elicited by luminal but not vascular glutamine in the jointly perfused small intestine and liver of the rat.

A Gardemann1, Y Watanabe, V Grosse, S Hesse, K Jungermann.   

Abstract

1. Previous studies have shown that an arterial-to-portal glucose concentration gradient may be an important signal for insulin-dependent net hepatic glucose uptake. It is not known whether intestinal factors also contribute to the regulation of hepatic glucose utilization. This problem was studied in a newly developed model which allows luminal perfusion of the small intestine via the pyloric sphincter and a combined vascular perfusion of the small intestine via the gastroduodenal artery and superior mesenteric artery, and of the liver via the hepatic artery and portal vein. 2. In both the presence and the absence of 1 mM-glutamine in the vascular perfusate, only about 7% of a luminal bolus of 5500 mumol (1 g) of glucose was absorbed by the small intestine, and nothing was taken up by the liver. 3. With small doses of 75-380 mumol (11-55 mg) of luminal glutamine, but not with 300 mumol of alanine, the intestinal absorption of the luminal glucose bolus was increased almost linearly from 7% to a maximum of 40% and the hepatic uptake from 0% to a maximum of 22%. 4. The increase of hepatic glucose uptake caused by luminal glutamine was only observed when the glucose load was applied into the intestinal lumen, rather than into the superior mesenteric artery. 5. The relative hepatic glucose uptake (uptake/portal supply) was enhanced from 0% to 55% with an increase in portal supply by luminal glutamine, whereas with a similar range of portal glucose supply the relative hepatic uptake by the isolated liver, perfused simultaneously via the hepatic artery and portal vein, was slightly decreased, from 20% to 15%. 6. Addition of various amounts of portal glutamine and/or alterations in the Na+ content of the portal perfusate failed to mimic the luminal glutamine-dependent activation of hepatic glucose uptake. Therefore the luminal-glutamine-elicited activation of hepatic glucose uptake was apparently not caused by a simple increase in the portal-arterial glucose gradient, by glutamine itself or by Na(+)-dependent alterations in hepatic cell volume. The results suggest that luminal glutamine caused not only an increase in intestinal glucose absorption by unknown mechanisms but also the generation of one or more humoral or nervous 'hepatotropic' signals in the small intestine which enhanced the hepatic uptake of absorbed glucose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590766      PMCID: PMC1130951          DOI: 10.1042/bj2830759

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Modulation by oxygen of the actions of noradrenaline, sympathetic nerve stimulation and prostaglandin F2 alpha on carbohydrate metabolism and hemodynamics in perfused rat liver.

Authors:  G Becker; U Beuers; K Jungermann
Journal:  Biol Chem Hoppe Seyler       Date:  1990-10

2.  Water, K+, H+, lactate and glucose fluxes during cell volume regulation in perfused rat liver.

Authors:  F Lang; T Stehle; D Häussinger
Journal:  Pflugers Arch       Date:  1989-01       Impact factor: 3.657

3.  Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver.

Authors:  H Hartmann; R Ebert; W Creutzfeldt
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

4.  A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver.

Authors:  A Gardemann; H Strulik; K Jungermann
Journal:  FEBS Lett       Date:  1986-07-07       Impact factor: 4.124

5.  Gastrointestinal peptides and insulin secretion.

Authors:  R Ebert; W Creutzfeldt
Journal:  Diabetes Metab Rev       Date:  1987-01

6.  Isolated perfused rat small bowel--technic, studies of viability, glucose absorption.

Authors:  H Kavin; N W Levin; M M Stanley
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

7.  Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect.

Authors:  K S Pang; W F Cherry; E H Ulm
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

8.  Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism.

Authors:  M Ghiglione; E Blazquez; L O Uttenthal; J G de Diego; E Alvarez; S K George; S R Bloom
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

Review 9.  Gastric inhibitory polypeptide: a gut hormone with anabolic functions.

Authors:  B Beck
Journal:  J Mol Endocrinol       Date:  1989-05       Impact factor: 5.098

10.  Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog.

Authors:  B A Adkins; S R Myers; G K Hendrick; R W Stevenson; P E Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more
  5 in total

Review 1.  Enhancing bowel adaptation in short bowel syndrome.

Authors:  Palle Bekker Jeppesen; Per Brobech Mortensen
Journal:  Curr Gastroenterol Rep       Date:  2002-08

2.  Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.

Authors:  J Szkudlarek; P B Jeppesen; P B Mortensen
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine.

Authors:  B Scholtka; F Stümpel; K Jungermann
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

4.  Intestinal injury can be reduced by intra-arterial postischemic perfusion with hypertonic saline.

Authors:  Oleg Kornyushin; Michael Galagudza; Anna Kotslova; Gelfia Nutfullina; Nina Shved; Alexey Nevorotin; Valeriy Sedov; Timur Vlasov
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

5.  A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.

Authors:  T A Byrne; R L Persinger; L S Young; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.